Promoted Content Promoted Content

X

Market Place

Market Place

Menu

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Prices
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type Full Screen

              Companies Full Screen

              Curia

              • Deals

              Virtual BoothA partner for the pharma and biotech industries to improve patient outcomes & quality of life

              UNITED STATES United States

              Contact Supplier Contact Supplier

              Virtual Booth Virtual Booth

              CPhI Japan 2022

              Booth # 1H-9

              Request a Meeting Now

              Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug

              Contact the Supplier

              Lead Product(s): Psilocybine

              Therapeutic Area: Psychiatry/Psychology Product Name: TRP-8802

              Highest Development Status: Undisclosed Product Type: Small molecule

              Partner/Sponsor/Collaborator: Tryp Therapeutics

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership August 13, 2020

              Details:

              AMRI will provide research, development and cGMP manufacturing of a proprietary psilocybin active pharmaceutical ingredient to support the clinical development of TRP-8802, TRP-8803 and TRP-8804 programs.

              Allied Corp

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              UNITED STATES United States

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              Virtual Innovation Day

              Participation Not Confirmed

              Update your events

              Allied Corp Signs Psilocybin Manufacturing Agreement To Produce Psilonex™ RX

              Contact the Supplier

              Lead Product(s): Psilocybine,Cordyceps,Lion\'s mane

              Therapeutic Area: Psychiatry/Psychology Product Name: Psilonex RX

              Highest Development Status: Undisclosed Product Type: Small molecule

              Partner/Sponsor/Collaborator: HAVN Life Sciences

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement June 30, 2021

              Details:

              Allied has under provisional patent the formulation and trademark for Psilonex™ RX. Along with this, Allied has access to a cohort of over 300 veterans, police, fire and ambulance personnel who are struggling with post trauma symptoms and are requesting Psilonex™ RX.

              PPD